Join your colleagues as we discuss: 1) The pathophysiology of hepatorenal syndrome (HRS) and associated burden of disease 2) Recent clinical data for a treatment option for HRS and implications for clinical practice and patient care Sponsored by Mallinckrodt Pharmaceuticals